HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1alpha degradation - PubMed (original) (raw)
HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1alpha degradation
E Berra et al. FEBS Lett. 2001.
Free article
Abstract
Hypoxia-inducible factor-1alpha (HIF-1alpha) plays a central role in oxygen homeostasis. In normoxia, HIF-1alpha is a short lived protein, whereas hypoxia rapidly increases HIF-1alpha protein levels by relaxing its ubiquitin-proteasome-dependent degradation. In this study, we show that the p42/p44 MAP kinase cascade, known to phosphorylate HIF-1alpha, does not modulate the degradation/stabilization profile of HIF-1alpha. However, we present evidence that the rate of HIF-1alpha degradation depends on the duration of hypoxic stress. We demonstrate that degradation of HIF-1alpha is suppressed by: (i) inhibiting general transcription with actinomycin D or (ii) specifically blocking HIF-1-dependent transcriptional activity. In keeping with these findings, we postulate that HIF-1alpha is targetted to the proteasome via a HIF-1alpha proteasome targetting factor (HPTF) which expression is directly under the control of HIF-1-mediated transcriptional activity. Although HPTF is not yet molecularly identified, it is clearly distinct from the von Hippel-Lindau protein (pVHL).
Similar articles
- Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K, Makino Y, Pereira T, Poellinger L. Tanimoto K, et al. EMBO J. 2000 Aug 15;19(16):4298-309. doi: 10.1093/emboj/19.16.4298. EMBO J. 2000. PMID: 10944113 Free PMC article. - The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. Maxwell PH, et al. Nature. 1999 May 20;399(6733):271-5. doi: 10.1038/20459. Nature. 1999. PMID: 10353251 - Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.
Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH. Cockman ME, et al. J Biol Chem. 2000 Aug 18;275(33):25733-41. doi: 10.1074/jbc.M002740200. J Biol Chem. 2000. PMID: 10823831 - Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
Mole DR, Maxwell PH, Pugh CW, Ratcliffe PJ. Mole DR, et al. IUBMB Life. 2001 Jul;52(1-2):43-7. doi: 10.1080/15216540252774757. IUBMB Life. 2001. PMID: 11795592 Review. - The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
Pugh CW, Ratcliffe PJ. Pugh CW, et al. Semin Cancer Biol. 2003 Feb;13(1):83-9. doi: 10.1016/s1044-579x(02)00103-7. Semin Cancer Biol. 2003. PMID: 12507560 Review.
Cited by
- Ets-1 as an early response gene against hypoxia-induced apoptosis in pancreatic β-cells.
Qiao N, Xu C, Zhu YX, Cao Y, Liu DC, Han X. Qiao N, et al. Cell Death Dis. 2015 Feb 19;6(2):e1650. doi: 10.1038/cddis.2015.8. Cell Death Dis. 2015. PMID: 25695603 Free PMC article. - Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective.
Rodríguez-Jiménez FJ, Moreno-Manzano V. Rodríguez-Jiménez FJ, et al. Cell Mol Life Sci. 2012 Feb;69(4):519-34. doi: 10.1007/s00018-011-0813-4. Epub 2011 Oct 8. Cell Mol Life Sci. 2012. PMID: 21984597 Free PMC article. Review. - HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications.
Zeng CY, Wang XF, Hua FZ. Zeng CY, et al. Front Pharmacol. 2022 Jul 5;13:927126. doi: 10.3389/fphar.2022.927126. eCollection 2022. Front Pharmacol. 2022. PMID: 35865944 Free PMC article. Review. - Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1.
To KK, Huang LE. To KK, et al. J Biol Chem. 2005 Nov 11;280(45):38102-7. doi: 10.1074/jbc.M504342200. Epub 2005 Sep 12. J Biol Chem. 2005. PMID: 16157596 Free PMC article. - NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC.
Bommi PV, Chand V, Mukhopadhyay NK, Raychaudhuri P, Bagchi S. Bommi PV, et al. Oncogene. 2020 Feb;39(8):1784-1796. doi: 10.1038/s41388-019-1105-y. Epub 2019 Nov 18. Oncogene. 2020. PMID: 31740787 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources